Published in J Antimicrob Chemother on September 26, 2013
Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy. Drugs (2014) 0.94
Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother (2015) 0.85
Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. Elife (2016) 0.80
Modelling challenges in context: lessons from malaria, HIV, and tuberculosis. Epidemics (2015) 0.78
Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities. Nanomaterials (Basel) (2014) 0.75
Correction: Unbiased Estimation of Mutation Rates under Fluctuating Final Counts. PLoS One (2017) 0.75
Next-generation approaches to understand and combat the antibiotic resistome. Nat Rev Microbiol (2017) 0.75
Comparing mutation rates under the Luria-Delbrück protocol. Genetica (2016) 0.75
Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med (1999) 8.80
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Oligonucleotide (GTG)5 as a marker for Mycobacterium tuberculosis strain identification. J Clin Microbiol (1994) 3.41
Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. J Clin Microbiol (2002) 3.12
Perceptual restoration of missing speech sounds. Science (1970) 3.08
A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol (2007) 2.83
Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis (2006) 2.78
Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis (2006) 2.78
Purification of sputum samples through sucrose improves detection of Mycobacterium tuberculosis by polymerase chain reaction. J Clin Microbiol (1992) 2.53
Isoniazid pharmacokinetics in children treated for respiratory tuberculosis. Arch Dis Child (2005) 2.39
Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis (1999) 2.31
Receptor types in cat hairy skin supplied by myelinated fibers. J Neurophysiol (1968) 2.10
Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis (2010) 2.00
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother (2007) 1.93
Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity. Mol Microbiol (2000) 1.92
Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis (2003) 1.88
Incidence of gonococci relatively resistant to penicillin occurring in the Southampton area of England during 1958 to 1965. Br J Vener Dis (1968) 1.87
The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid. Clin Infect Dis (2004) 1.87
The burden of childhood tuberculosis: a public health perspective. Int J Tuberc Lung Dis (2005) 1.86
Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis (Edinb) (2008) 1.81
Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis (1999) 1.77
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med (1997) 1.74
A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob Agents Chemother (2009) 1.74
Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol (2004) 1.73
Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol (2006) 1.71
The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay. J Clin Microbiol (2012) 1.70
Disruption of coding regions by IS6110 insertion in Mycobacterium tuberculosis. Tuber Lung Dis (1999) 1.67
Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis (2010) 1.67
Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol (2002) 1.62
Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis (2008) 1.62
Evolution of the IS6110-based restriction fragment length polymorphism pattern during the transmission of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.55
Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis (2006) 1.53
Genotyping of Mycobacterium tuberculosis with additional markers enhances accuracy in epidemiological studies. J Clin Microbiol (1996) 1.51
Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax (1999) 1.50
Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging (2000) 1.47
Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis (2012) 1.47
Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J Clin Microbiol (2008) 1.46
Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis (2006) 1.46
Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb) (2011) 1.44
Expression, characterization and subcellular localization of the Mycobacterium tuberculosis PPE gene Rv1917c. Tuberculosis (Edinb) (2001) 1.44
Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependent. J Clin Microbiol (2007) 1.42
Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive element-based DNA fingerprinting. Tuberculosis (Edinb) (2001) 1.42
Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol (2004) 1.36
Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa. Int J Tuberc Lung Dis (2007) 1.33
Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis (2010) 1.32
Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother (2012) 1.31
Adult-to-child transmission of tuberculosis: household or community contact? Int J Tuberc Lung Dis (2003) 1.31
The mycosins of Mycobacterium tuberculosis H37Rv: a family of subtilisin-like serine proteases. Gene (2000) 1.31
Hypomethylation of DNA in pathological conditions of the human prostate. Cancer Res (1987) 1.30
Increasing the intelligibility of speech through multiple phonemic restorations. Percept Psychophys (1992) 1.26
Auditory induction: perceptual synthesis of absent sounds. Science (1972) 1.24
Molecular evolution of Mycobacterium tuberculosis: phylogenetic reconstruction of clonal expansion. Tuberculosis (Edinb) (2001) 1.24
Fine needle aspiration biopsy: an undervalued diagnostic modality in paediatric mycobacterial disease. Int J Tuberc Lung Dis (2009) 1.22
Novel method for rapid measurement of growth of mycobacteria in detergent-free media. J Clin Microbiol (1998) 1.20
Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis (Edinb) (2010) 1.20
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid. Eur J Clin Pharmacol (2007) 1.20
Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J Clin Microbiol (2001) 1.17
inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Int J Tuberc Lung Dis (2011) 1.17
How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? Clin Radiol (1999) 1.17
Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis (2004) 1.14
Improved method for the routine identification of toxigenic Escherichia coli by DNA amplification of a conserved region of the heat-labile toxin A subunit. J Clin Microbiol (1991) 1.14
An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis (2006) 1.14
Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa. Int J Tuberc Lung Dis (2007) 1.13
Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex. J Clin Microbiol (2008) 1.13
Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrob Agents Chemother (2012) 1.12
The clinical relevance of Mycobacterial pharmacogenetics. Tuberculosis (Edinb) (2009) 1.11
Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clin Microbiol Infect (2011) 1.11
Historic and recent events contribute to the disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high incidence region. Int J Tuberc Lung Dis (2002) 1.10